Castle Rock Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Buy	4,054 +353	+10%	+$169K	0.41%	74
2026 Q1	$1.82M	Buy	3,701 +34	+0.9%	+$18.5K	0.39%	75
2025 Q4	$2.09M	Buy	3,667 +76	+2%	+$43K	0.45%	65
2025 Q3	$1.88M	Buy	3,591 +46	+1%	+$21.4K	0.42%	66
2025 Q2	$1.46M	Buy	3,545 +347	+11%	+$145K	0.34%	85
2025 Q1	$1.56M	Sell	3,198 -131	-4%	-$70.9K	0.42%	62
2024 Q4	$1.77M	Buy	3,329 +167	+5%	+$91.8K	0.42%	64
2024 Q3	$1.89M	Buy	3,162 +57	+2%	+$33.7K	0.45%	60
2024 Q2	$1.68M	Buy	3,105 +115	+4%	+$65.9K	0.42%	65
2024 Q1	$1.72M	Buy	2,990 +1,189	+66%	+$667K	0.47%	56
2023 Q4	$956K	Buy	1,801 +161	+10%	+$77.9K	0.29%	95
2023 Q3	$819K	Buy	1,640 +43	+3%	+$22.9K	0.28%	91
2023 Q2	$831K	Buy	1,597 +66	+4%	+$35.6K	0.28%	85
2023 Q1	$819K	Buy	1,531 +22	+1%	+$12.4K	0.29%	73
2022 Q4	$871K	Buy	1,509 +30	+2%	+$15.9K	0.39%	65
2022 Q3	$741K	Sell	1,479 -18	-1%	-$10.1K	0.37%	69
2022 Q2	$829K	Sell	1,497 -284	-16%	-$156K	0.42%	57
2022 Q1	$1.02M	Sell	1,781 -1,651	-48%	-$948K	0.47%	50
2021 Q4	$1.99M	Sell	3,432 -22	-0.6%	-$13.7K	0.81%	32
2021 Q3	$2.16M	Buy	3,454 +191	+6%	+$105K	0.74%	33
2021 Q2	$1.76M	Buy	3,263 +364	+13%	+$172K	0.65%	39
2021 Q1	$1.4M	Buy	2,899 +244	+9%	+$116K	0.57%	57
2020 Q4	$1.37M	Buy	2,655 +298	+13%	+$140K	0.57%	50
2020 Q3	$1.1M	Buy	2,357 +1,067	+83%	+$441K	0.72%	44
2020 Q2	$536K	Buy	+1,290	New	+$432K	0.31%	110
2020 Q1	–	Sell	-4,130	Closed	-$1.4M	–	183
2019 Q4	$1.4M	Buy	+4,130	New	+$1.25M	1.26%	13
2019 Q3	–	Sell	-800	Closed	-$236K	–	189
2019 Q2	$236K	Buy	+800	New	+$220K	0.26%	118

Other funds holding TMO